Last edition
News about "Non-Small Cell Lung Cancer (NSCLC) diagnostics"
Lung Cancer Canada and Boehringer Ingelheim Canada Partner to Advance NSCLC Diagnostics
Lung Cancer Canada and Boehringer Ingelheim have launched a two-stage initiative to accelerate innovation in NSCLC diagnostics. The effort begins with a national Diagnostic Innovation Lab to identify key barriers in diagnosis, followed by an innovation challenge seeking solutions to close those gaps.
Non-Small Cell Lung Cancer (NSCLC) Diagnostics | 29/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy